Divaza

DRUG2 trials

Sponsors

Materia Medica Holding

Conditions

Cerebral AtherosclerosisChronic Cerebral Ischemia

Phase 4

Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis

CompletedNCT03485495

Materia Medica HoldingCerebral Atherosclerosis

Start: 2018-04-12End: 2019-04-11Updated: 2021-08-26

Unknown Phase

Study on Efficacy and Safety of Divaza in Patients With Chronic Cerebral Ischemia and Cognitive Disorders

CompletedNCT04370028

Materia Medica HoldingChronic Cerebral Ischemia

Start: 2016-10-31End: 2017-01-31Updated: 2021-03-10